Royalty Pharma and Cytokinetics Announce Expanded Strategic
Deal provides Cytokinetics with diversified access to capital as company advances its specialty cardiology franchise NEW YORK and SOUTH SAN FRANCISCO,...
Source: globenewswire.com
Functional Class News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Functional Class. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Functional Class Today - Breaking & Trending Today
Cytokinetics Presents Additional 48-Week Data from Forest-Hcm, the Open Label Extension Clinical Study of Aficamten, At the American College of Cardiology 73rd Annual Scientific Session
Cytokinetics, Incorporated announced additional 48-week data from FOREST-HCM , the open label extension clinical study of aficamten in patients with hypertrophic cardiomyopathy , at the 73rd Annual...
Source: marketscreener.com
FDA OKs First-in-Class Sotatercept for PAH
Sotatercept with background therapy significantly improved exercise capacity and multiple secondary outcome measures compared to background therapy alone in the STELLAR trial.
Source: medscape.com
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
Preparing to launch YUTREPIA™ inhalation powder upon final FDA approvalFederal Circuit rejected request by United Therapeutics for rehearing of earlier decision finding ‘793 Patent...
Source: marketscreener.com
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
MORRISVILLE, N.C., Jan. 25, 2024 -- Liquidia Corporation announced today that the U.S. Food and Drug Administration provided an update on its review of the New Drug Application for YUTREPIA™ ...
Source: marketscreener.com